Literature DB >> 23601661

Selective photocrosslinking of functional ligands to antibodies via the conserved nucleotide binding site.

Nathan J Alves1, Matthew M Champion, Jared F Stefanick, Michael W Handlogten, Demetri T Moustakas, Yunhua Shi, Bryan F Shaw, Rudolph M Navari, Tanyel Kiziltepe, Basar Bilgicer.   

Abstract

The conserved nucleotide binding site (NBS), found in the Fab variable domain of all antibody isotypes, remains a not-so-widely known and under-utilized site. Here, we describe a UV photocrosslinking method (UV-NBS) that utilizes the NBS for site-specific covalent functionalization of antibodies, while preserving antibody activity. We identified a small molecule, indole-3-butyric acid (IBA), which has affinity for the NBS (K(d) = 1-8 μM) and can be photocrosslinked to antibodies upon UV energy exposure. By synthesizing their IBA conjugated versions, we have successfully photocrosslinked various types of functional ligands to antibodies at the NBS, including affinity tags (biotin), fluorescent molecules (FITC), peptides (iRGD), and chemotherapeutics (paclitaxel). An optimal UV exposure of 1-2 J/cm(2) yielded the most efficient photocrosslinking and resulted in 1-2 conjugations per antibody, while preserving the antigen binding activity and Fc related functions. Analysis of the photocrosslinked conjugates using western blotting, mass spectrometry, and computational docking simulations demonstrated that the photocrosslinking specifically takes place at the Y/F42 residue in framework region 2 of the antibody light chain. Taken together, the UV-NBS method provides a practical, site-specific, and chemically efficient method to functionalize antibodies with significant implications in diagnostic and therapeutic settings.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601661     DOI: 10.1016/j.biomaterials.2013.03.082

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  Site-specific conjugation of an antibody on a gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Nanoscale       Date:  2017-06-29       Impact factor: 7.790

Review 2.  Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.

Authors:  Jessica R McCombs; Shawn C Owen
Journal:  AAPS J       Date:  2015-01-22       Impact factor: 4.009

3.  Identification of disulfide bond isomerase substrates reveals bacterial virulence factors.

Authors:  Guoping Ren; Matthew M Champion; Jason F Huntley
Journal:  Mol Microbiol       Date:  2014-10-20       Impact factor: 3.501

4.  Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine Model.

Authors:  Peter E Deak; Baksun Kim; Byunghee Koh; Amina Abdul Qayum; Tanyel Kiziltepe; Mark H Kaplan; Basar Bilgicer
Journal:  J Immunol       Date:  2019-05-17       Impact factor: 5.422

5.  Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Analyst       Date:  2016-11-28       Impact factor: 4.616

6.  A heterobivalent ligand inhibits mast cell degranulation via selective inhibition of allergen-IgE interactions in vivo.

Authors:  Michael W Handlogten; Ana P Serezani; Anthony L Sinn; Karen E Pollok; Mark H Kaplan; Basar Bilgicer
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

7.  Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation.

Authors:  Michael W Handlogten; Tanyel Kiziltepe; Ana P Serezani; Mark H Kaplan; Basar Bilgicer
Journal:  Nat Chem Biol       Date:  2013-10-06       Impact factor: 15.040

Review 8.  Current Conjugation Methods for Immunosensors.

Authors:  Zeyang Li; Guan-Yu Chen
Journal:  Nanomaterials (Basel)       Date:  2018-04-26       Impact factor: 5.076

Review 9.  Site-selective lysine conjugation methods and applications towards antibody-drug conjugates.

Authors:  Muhammed Haque; Nafsika Forte; James R Baker
Journal:  Chem Commun (Camb)       Date:  2021-10-14       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.